Publications and communications of François Jouret

Cirillo, A., Résimont, G., Jouret, F., Vidal-Petiot, E., Flamant, M., Delanaye, P., & De Tullio, P. (31 January 2024). How can metabolomics help the follow-up management of kidney transplantation recipients? An untargeted based-metabolomics multiplatform study [Paper presentation]. Metabolomics in Life Science, Umea, Sweden.

Demuynck, S., Lovinfosse, P., Seidel, L., Jentjens, S., Mekahli, D., Jouret, F., Bammens, B., & Goffin, K. (December 2023). Standardized 4-point scoring scale of [18F]-FDG PET/CT imaging helps in the diagnosis of renal and hepatic cyst infections in patients with autosomal dominant polycystic kidney disease: a validation cohort. Clinical Kidney Journal, 16 (12), 2542 - 2548. doi:10.1093/ckj/sfad159

Pinto Coelho, T., ERPICUM, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (December 2023). La mort cérébrale affecte différemment les greffons rénaux par rapport à l’arrêt circulatoire brutal [Paper presentation]. Congrès Annuel Société Francophone de Transplantation, Brest, France.

Rega, L. R., Janssens, V., Graversen, J. H., Moestrup, S. K., Cairoli, S., Goffredo, B. M., Nevo, N., Courtoy, G. E., Jouret, F., Antignac, C., Emma, F., Pierreux, C. E., & Courtoy, P. J. (12 October 2023). Dietary supplementation of cystinotic mice by lysine inhibits the megalin pathway and decreases kidney cystine content. Scientific Reports, 13 (1), 17276. doi:10.1038/s41598-023-43105-x

Pinto Coelho, T., Erpicum, P., Navez, M., Chenyu, Z., Detry, O., & Jouret, F. (25 September 2023). LA MORT ENCÉPHALIQUE AFFECTE LES GREFFONS RÉNAUX DE FAÇON DIFFÉRENTE PAR RAPPORT À L’ARRÊT CIRCULATOIRE BRUTAL. Néphrologie et Thérapeutique, 19 (5), 370 - 463. doi:10.1684/ndt.2023.43

Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751
* These authors have contributed equally to this work.

Masson, G., Viva, T., Huart, J., Weekers, L., BONVOISIN, C., Bouquegneau, A., MAWEJA, S., Hamoir, E., Seidel, L., Pottel, H., Lancellotti, P., & Jouret, F. (01 August 2023). The Effect of Elective Ligation of the Arteriovenous Fistula on Cardiac and Renal Functions in Kidney Transplant Recipients. Kidney360, 4 (8), 1130 - 1138. doi:10.34067/KID.0000000000000198

Cirillo, A., Vandermeulen, M., Erpicum, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (18 June 2023). Untargeted 1H NMR-based analysis of kidney allograft perfusates identifies a metabolomics signature of delayed graft function [Poster presentation]. Metabolomics Society, Niagara Falls, Canada.

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (June 2023). #3687 KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING. Nephrology Dialysis Transplantation, 38 (Supplement 1), 913. doi:10.1093/ndt/gfad063c_3687

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.

Huart, J., Persu, A., Lengelé, J.-P., Krzesinski, J.-M., Jouret, F., & Stergiou, G. (2023). Pathophysiology of the Nondipping Blood Pressure Pattern. Hypertension. doi:10.1161/HYPERTENSIONAHA.122.19996

Khbouz, B., Gu, S., Pinto Coelho, T., LALLEMAND, F., & Jouret, F. (05 January 2023). Radiotherapy Advances in Renal Disease—Focus on Renal Ischemic Preconditioning. Bioengineering, 10 (1), 68. doi:10.3390/bioengineering10010068

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (2023). KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING [Paper presentation]. ESOT congress 2023, Athens, Greece.

Résimont, G., VRANKEN, L., Pottel, H., JOURET, F., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (27 June 2022). Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations. Clinical Chemistry and Laboratory Medicine, 60 (7), 1064-1072. doi:10.1515/cclm-2022-0049

Cirillo, A., Résimont, G., Delanaye, P., Emmanuelle Vidal-Petiot, Martin Flamant, Jouret, F., & De Tullio, P. (19 June 2022). Application of metabolomics to the evaluation of kidney function and kidney transplantation [Poster presentation]. Metabolomics Society.

BOUQUEGNEAU, A., MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., CAVALIER, E., & DELANAYE, P. (May 2022). Bone Mineral Density, Bone Micro-Architecture Evolution After Kidney Transplantation: A Prospective Cohort Study. Nephrology Dialysis Transplantation, 37 (Supplement_3). doi:10.1093/ndt/gfac073.006

ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344.

GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337.

GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211.

VALDES SOCIN, H. G., SCHEEN, A., JOURET, F., GROSCH, S., & DELANAYE, P. (March 2022). De la découverte de la phlorizine (une histoire belge) aux inhibiteurs des SGLT2. Revue Médicale de Liège, 77 (3), 175-180.

Dachy, A., Decuypère, J.-P., Vennekens, R., Jouret, F., & mekahli, D. (2022). Is autosomal dominant polycystic kidney disease an early sweet disease? Pediatric Nephrology. doi:10.1007/s00467-021-05406-z

DELANAYE, P., DUBOIS, B., CAVALIER, E., & JOURET, F. (2022). Vignette diagnostique de l’étudiant : approche diagnostique de la maladie rénale chronique. Revue Médicale de Liège, 7 (4), 249-252.

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., JOURET, F., & DETRY, O. (2022). Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats. Frontiers in Immunology, 13, 877953. doi:10.3389/fimmu.2022.877953

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323

Firket, L., Descy, J., Seidel, L., Bonvoisin, C., Bouquegneau, A., Grosch, S., Jouret, F., & Weekers, L. (November 2021). Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21 (11), 3806-3807. doi:10.1111/ajt.16726

Malisoux, C., KOCH, J.-N., MEURISSE, N., Lagny, M., VANDERMEULEN, M., HONORE, P., JOURET, F., DELANAYE, P., & DETRY, O. (August 2021). Perioperative risk factors of acute kidney injury post liver transplantation: a monocentric retrospective cohort study of 260 patients. Transplant International, 34 (S1 POS315), 312.

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., Drion, P., JOURET, F., & DETRY, O. (August 2021). Mesenchymal stromal cells combined with everolimus promote Treg expansion but do not synergize in a rat liver transplant rejection model. Transplant International, 34 (S1 OP519), 101.

Cirillo, A., Huart, J., Taminiau, B., Descy, J., Saint-Remy, A., Daube, G., KRZESINSKI, J.-M., MELIN, P., JOURET, F., & De Tullio, P. (26 May 2021). Human Stool Metabolome Differs upon 24 h Blood Pressure Levels and Blood Pressure Dipping Status: A Prospective Longitudinal Study [Poster presentation]. CIRM day.

HUART, J.* , Cirillo, A.* , Taminiau, B., DESCY, J., SAINT-REMY, A., Daube, G., KRZESINSKI, J.-M., MELIN, P., De Tullio, P.* , & JOURET, F.*. (29 April 2021). Human Stool Metabolome Differs upon 24 h Blood Pressure Levels and Blood Pressure Dipping Status: A Prospective Longitudinal Study. Metabolites, 11 (5), 282. doi:10.3390/metabo11050282
* These authors have contributed equally to this work.

HUART, J.* , Cirillo, A.* , SAINT-REMY, A., KRZESINSKI, J.-M., De Tullio, P.* , & Jouret, F.*. (2021). The faecal abundance of short chain fatty acids is increased in men with a non-dipping blood pressure profile. Acta Cardiologica. doi:10.1080/00015385.2021.1901020
* These authors have contributed equally to this work.

Detry, O., MEURISSE, N., Jouret, F., BLETARD, N., Delwaide, J., & Moutschen, M. (February 2021). Immunosuppression Withdrawal After Liver Transplantation for Common Variable Immunodeficiency. Liver Transplantation, 27 (3), 456-458. doi:10.1002/lt.25873

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

DELANAYE, P., HUART, J., BOUQUEGNEAU, A., & JOURET, F. (2021). Long-term effects of COVID-19 on kidney function [letter to the editor]. The Lancet, 397 (10287), 1807. doi:10.1016/S0140-6736(21)00881-3

LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0

VALDES SOCIN, H. G., JOURET, F., VROONEN, L., SCHEEN, A., & LANCELLOTTI, P. (2021). Système rénine-angiotensine-aldostérone : bref historique et questionnements face à la pandémie COVID-19. Revue Médicale de Liège, 75, 123-129.

Vandermeulen, M., ERPICUM, P., POMA, L., Detry, O., & JOURET, F. (11 March 2020). Impact of mesenchymal stromal cells and/or everolimus on T-reg lymphocyte expansion in rats [Paper presentation]. Annual Meeting, Antwerp, Belgium.

BOVY, C., DELANAYE, P., JOURET, F., & KRZESINSKI, J.-M. (2020). Nouveautés thérapeutiques en Néphrologie : 10 ans d'avancées. Revue Médicale de Liège, 75 (5-6), 336-343.

ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114.

HUART, J., KRZESINSKI, J.-M., & JOURET, F. (2020). Argument en faveur d'un rôle du microbiote intestinal dans la physiopathologie de l'hypertension artérielle. Revue Médicale de Liège, 75 (9), 588-592.

Janssens, P., Jouret, F., Bammens, B., Liebau, M. C., Schaefer, F., Dandurand, A., Perrone, R. D., Muller, R.-U., Pao, C. S., & Mekahli, D. (2020). Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial. Scientific Reports, 10 (1), 4294. doi:10.1038/s41598-020-61303-9

Jouret, F., & Devuyst, O. (2020). Targeting chloride transport in autosomal dominant polycystic kidney disease. Cellular Signalling, 73, 109703. doi:10.1016/j.cellsig.2020.109703

Neuville, M., Krzesinski, J.-M., & Jouret, F. (2020). Serum levels of carbohydrate antigen 19-9 do not systematically increase in case of liver cyst infection in patients with autosomal dominant polycystic kidney disease [letter to the editor]. Clinical Kidney Journal, 13 (3), 482-483. doi:10.1093/ckj/sfz119

PAQUOT, F., WEEKERS, L., BONVOISIN, C., Pottel, H., & Jouret, F. (01 July 2019). "Acute kidney dysfunction with no rejection" is associated with poor renal outcomes at 2 years post kidney transplantation. BMC Nephrology, 20 (1), 249. doi:10.1186/s12882-019-1444-5

Andries, A., Daenen, K., Jouret, F., Bammens, B., Mekahli, D., & Van Schepdael, A. (2019). Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression? Pediatric Nephrology. doi:10.1007/s00467-018-4004-5

Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., & Bammens, B. (2019). Oxidative stress in chronic kidney disease. Pediatric Nephrology. doi:10.1007/s00467-018-4005-4

Rowart, P., Wu, J., Caplan, M. J., & Jouret, F. (2018). Implications of AMPK in the Formation of Epithelial Tight Junctions. International Journal of Molecular Sciences. doi:10.3390/ijms19072040

HUART, J., Leenders, J., Taminiau, B., DESCY, J., SAINT-REMY, A., Daube, G., KRZESINSKI, J.-M., MELIN, P., De Tullio, P., & JOURET, F. (18 May 2018). GUT MICROBIOTA AND FAECAL LEVELS OF SHORT CHAIN FATTY ACIDS DIFFER UPON BLOOD PRESSURE LEVELS IN MAN. Nephrology Dialysis Transplantation, 33 (Issue suppl_1), 368–i369. doi:10.1093/ndt/gfy104.SP069

Bakker, J., Balthazart, J., Baron, F., Beguin, Y., Bettendorff, L., Blanpain, C., Bureau, F., Caers, J., Cani, P., Cataldo, D., Cornil, C., Clercx, C., Cloots, R., Colige, A., Daube, G., De Backer, O., de Kerchove d'Exaerde, A., Desmecht, D., Desmet, C., ... Wittamer, V. (2018). La souris, le patient, et le faux expert. Décryptage d'une mystification. Le Vif. L'Express.

ERPICUM, P., Rowart, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2018). What we need to know about lipid-associated injury in case of renal ischemia/reperfusion. American Journal of Physiology. Renal Physiology. doi:10.1152/ajprenal.00322.2018

Grieco, G., Janssens, V., Gaide Chevronnay, H. P., N'Kuli, F., Van Der Smissen, P., Wang, T., Shan, J., Vainio, S., Bilanges, B., Jouret, F., Vanhaesebroeck, B., Pierreux, C. E., & Courtoy, P. J. (2018). Vps34/PI3KC3 deletion in kidney proximal tubules impairs apical trafficking and blocks autophagic flux, causing a Fanconi-like syndrome and renal insufficiency. Scientific Reports, 8 (1), 14133. doi:10.1038/s41598-018-32389-z

HUART, J., Krzesinski, J.-M., & Jouret, F. (2018). Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literature. Clinical Kidney Journal, 11 (4), 586-596. doi:10.1093/ckj/sfy020

Meijers, B., Jouret, F., & Evenepoel, P. (2018). Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease. Pharmacological Research, 133, 101-107. doi:10.1016/j.phrs.2018.04.023

PAQUOT, F., DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., Evenepoel, P., & CAVALIER, E. (2018). Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients [letter to the editor]. Clinica Chimica Acta, 486, 183-184. doi:10.1016/j.cca.2018.08.003

Vanderweckene, P., Weekers, L., Lancellotti, P., & Jouret, F. (2018). Controversies in the management of the haemodialysis-related arteriovenous fistula following kidney transplantation. Clinical Kidney Journal, 11 (3), 406-412. doi:10.1093/ckj/sfx113

Yakulov, T. A., Todkar, A. P., Slanchev, K., Wiegel, J., Bona, A., Gross, M., Scholz, A., Hess, I., Wurditsch, A., Grahammer, F., Huber, T. B., Lecaudey, V., Bork, T., Hochrein, J., Boerries, M., Leenders, J., De Tullio, P., Jouret, F., Kramer-Zucker, A., & Walz, G. (2018). CXCL12 and MYC control energy metabolism to support adaptive responses after kidney injury. Nature Communications, 9 (1), 3660. doi:10.1038/s41467-018-06094-4

Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., ... Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique.

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (September 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and modulates renal lipid metabolism in rats. Transplant International, 30 (S2), 9 (OS004.

VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051.

ERPICUM, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (August 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats. Scientific Reports, 7 (1), 8687. doi:10.1038/s41598-017-08726-z

Rowart, P., ERPICUM, P., KRZESINSKI, J.-M., Sebbagh, M., & JOURET, F. (2017). Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1. Stem Cells International. doi:10.1155/2017/9717353

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & Jouret, F. (16 March 2017). intravenous administration of mesenchymal stream cells modulates renal lipid metabolism in rats [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium.

WEEKERS, L., ERPICUM, P., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (16 March 2017). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium.

De Rechter, S., Kringen, J., Janssens, P., Liebau, M. C., Devriendt, K., Levtchenko, E., Bergmann, C., Jouret, F., Bammens, B., Borry, P., Schaefer, F., & Mekahli, D. (2017). Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease. PLoS ONE, 12 (9), 0185779. doi:10.1371/journal.pone.0185779

DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., & CAVALIER, E. (2017). Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Scientific Reports, 7 (1), 12623. doi:10.1038/s41598-017-12808-3

Erpicum, P., HANSSEN, O., WEEKERS, L., LOVINFOSSE, P., Meunier, P., TSHIBANDA, L., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. NDT Plus, 1-10. doi:10.1093/ckj/sfw077

GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc.

HANSSEN, O., Erpicum, P., LOVINFOSSE, P., Meunier, P., WEEKERS, L., TSHIBANDA, L., Krzesinski, J.-M., HUSTINX, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clinical Kidney Journal, 10 (1), 97-105. doi:10.1093/ckj/sfw062

Maillard, N., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). Les pentes d’évolution des CTX, de la phosphatase alkaline osseuse et du P1NP sont associées à celles de la PTH en hémodialyse chronique [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

PIRAPREZ, M., QUINONEZ, K., SEMPELS, M., Waltregny, D., Krzesinski, J.-M., & Jouret, F. (2017). Obstruction urinaire basse : Attention à la levée d'obstacle ! Revue Médicale de Liège, 72 (12), 529-533.

Sayyed, S. A., JOURET, F., Vermeersch, M., Pérez-Morga, D., & Schurmans, S. (2017). The lipid 5-phoshatase SHIP2 controls renal brush border ultrastructure and function by regulating ERM proteins activation. Kidney International. doi:10.1016/j.kint.2017.01.008

Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (18 November 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. American Society of Nephrology | Kidney Week, Chicago, United States.

Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (27 October 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. MiSOT 2016 - The 6th Expert Meeting on Therapeutic MSCs for Immune Modulation, Regensburg, Germany.

Jouret, F., Leenders, J., Defraigne, J.-O., Krzesinski, J.-M., & De Tullio, P. (22 September 2016). Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion Injury. PLoS ONE, 11 (9), 1-14. doi:10.1371/journal.pone.0163021

NEUVILLE, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (2016). Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease. PLoS ONE. doi:10.1371/journal.pone.0161277

Neuville, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (23 May 2016). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease [Poster presentation]. 53 rd congress ERA-EDTA, Vienna, Austria.

Erpicum, P., WEEKERS, L., DETRY, O., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (28 April 2016). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (28 April 2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients is not Influenced by Renal Function [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

DELANAYE, P., LE GOFF, C., JOURET, F., & CAVALIER, E. (2016). Concordance between Iothalamate and Iohexol Plasma Clearance [letter to the editor]. American Journal of Kidney Diseases, 68 (2), 329-330. doi:10.1053/j.ajkd.2016.01.007

Gilissen, J., Jouret, F., Pirotte, B., & Hanson, J. (2016). Insight into SUCNR1 (GPR91) structure and function. Pharmacology and Therapeutics. doi:10.1016/j.pharmthera.2016.01.008

Grahammer, F., Ramakrishnan, S. K., Rinschen, M. M., Larionov, A. A., Syed, M., Khatib, H., Roerden, M., Sass, J. O., Helmstaedter, M., Osenberg, D., Kuhne, L., Kretz, O., Wanner, N., Jouret, F., Benzing, T., Artunc, F., Huber, T. B., & Theilig, F. (2016). mTOR Regulates Endocytosis and Nutrient Transport in Proximal Tubular Cells. Journal of the American Society of Nephrology. doi:10.1681/ASN.2015111224

JADOUL, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., KRZESINSKI, J.-M., HUSTINX, R., & JOURET, F. (2016). The uptake of 18F-FDG by renal allograft in kidney transplant recipients is not influenced by renal function [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

JOURET, F., CAVALIER, E., & DELANAYE, P. (2016). Concordance between iothalamate and iohexol plasma clearances [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

LOVINFOSSE, P.* , Weekers, L.* , BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & JOURET, F. (2016). Fluorodeoxyglucose F Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. American Journal of Transplantation. doi:10.1111/ajt.13429
* These authors have contributed equally to this work.

Marx, B., Scuvee, E., Scuvée-Moreau, J., Seutin, V., & Jouret, F. (2016). Mecanismes de l'effet diuretique de la cafeine. MS. Medecine Sciences, 32 (5), 485-90. doi:10.1051/medsci/20163205015

WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6.

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (November 2015). Impact of timing administration of mesenchymal stromal cells on serum creatinine following renal ischemia/ reperfusion in rats. Transplant International, 28 (S4), 11/O29.

WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278.

Neuville, M., Hustinx, R., Krzesinski, J.-M., & Jouret, F. (09 October 2015). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease [Poster presentation]. BENELUX kidney meeting, Eindhoven, Netherlands.

Erpicum, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (September 2015). Impact du moment d’administration des cellules stromales mésenchymateuses sur la fonction rénale lors d’une ischémie/reperfusion rénale. Néphrologie et Thérapeutique, 11 (5), 257. doi:10.1016/j.nephro.2015.07.002

WEEKERS, L., LOVINFOSSE, P., BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (September 2015). Place de la tomographie à émission de positons au 18FDG couplée à la tomodensitométrie en cas de suspicion de rejet aigu du greffon rénal. Néphrologie et Thérapeutique, 11 (5), 280.

WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3).

Rowart, P., ERPICUM, P., Defraigne, J.-O., KRZESINSKI, J.-M., & JOURET, F. (24 April 2015). Renal ischemia/reperfusion decreases the expression of DPP-4 [Paper presentation]. BELGIAN SOCIETY OF PHYSIOLOGY AND PHARMACOLOGY, Bruxelles, Belgium.

Castiglione, V., JOURET, F., Bruyère, O., DUBOIS, B., THOMAS, A., WALTREGNY, D., BEKAERT, A.-C., CAVALIER, E., & GADISSEUR, R. (February 2015). Epidémiologie de la lithiase urinaire sur base d'une analyse morpho-constitutionnelle. Néphrologie et Thérapeutique, 11, 42-49. doi:10.1016/j.nephro.2014.08.003

WEEKERS, L., De Tullio, P., BOVY, C., Poma, L., Marée, R., BONVOISIN, C., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (30 January 2015). Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury. American Journal of Translational Research, 7 (1), 128-138.

Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7

Lagny, M.-G., Jouret, F., Koch, J.-N., Blaffart, F., Donneau, A.-F., Albert, A., ROEDIGER, L., Krzesinski, J.-M., & Defraigne, J.-O. (2015). Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification. BMC Nephrology, 16 (1), 76. doi:10.1186/s12882-015-0066-9

Onclinx, C., Dogne, S., Jadin, L., Andris, F., Grandfils, C., Jouret, F., Mullier, F., & Flamion, B. (2015). Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy. Haematologica. doi:10.3324/haematol.2015.123828

Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.

Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (17 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège [Paper presentation]. Confrontations clinico-biologiques autour de la lithiase urinaire, Paris, France.

Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (01 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538

ERPICUM, P., Krzesinski, J.-M., & Jouret, F. (2014). Place de l'AMP-activated protein kinase dans le preconditionnement ischemique renal. Néphrologie et Thérapeutique. doi:10.1016/j.nephro.2013.10.006

JOURET, F., & Krzesinski, J.-M. (2013). Tolvaptan in autosomal dominant polycystic kidney disease [letter to the editor]. New England Journal of Medicine, 368 (13), 1258-9.

Jouret, F., Wu, J., Hull, M., Rajendran, V., Mayr, B., Schofl, C., Geibel, J., & Caplan, M. J. (2013). Activation of the Ca(2)+-sensing receptor induces deposition of tight junction components to the epithelial cell plasma membrane. Journal of Cell Science, 126 (Pt 22), 5132-42. doi:10.1242/jcs.127555

DELANAYE, P., DUBOIS, B., JOURET, F., KRZESINSKI, J.-M., & Moranne, O. (2012). Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? [Poster presentation]. American Society of Nephrology, San Diego, United States - California.

Ho, T. T., Labriola, L., JOURET, F., Yombi, J. C., Lecouvet, F., Jadoul, M., & Demoulin, N. (2012). Clostridium perfringens hip arthritis in a haemodialysis patient. Acta Clinica Belgica, 67 (1), 49-50. doi:10.2143/ACB.67.1.2062628

JOURET, F., Lhommel, R., Devuyst, O., Annet, L., Pirson, Y., Hassoun, Z., & Kanaan, N. (2012). Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrology Dialysis Transplantation, 27 (10), 3746-51. doi:10.1093/ndt/gfs352

JOURET, F., Courtoy, P. J., & Devuyst, O. (2011). Segmental and subcellular distribution of CFTR in the kidney. Methods in Molecular Biology, 741, 285-99. doi:10.1007/978-1-61779-117-8_19

JOURET, F., Lhommel, R., Beguin, C., Devuyst, O., Pirson, Y., Hassoun, Z., & Kanaan, N. (2011). Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology, 6 (7), 1644-50. doi:10.2215/CJN.06900810

Raggi, C., Fujiwara, K., Leal, T., JOURET, F., Devuyst, O., & Terryn, S. (2011). Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease. Pflügers Archiv: European Journal of Physiology, 462 (6), 851-60. doi:10.1007/s00424-011-1026-2

Zhang, L., JOURET, F., Rinehart, J., Sfakianos, J., Mellman, I., Lifton, R. P., Young, L. H., & Caplan, M. J. (2011). AMP-activated protein kinase (AMPK) activation and glycogen synthase kinase-3beta (GSK-3beta) inhibition induce Ca2+-independent deposition of tight junction components at the plasma membrane. Journal of Biological Chemistry, 286 (19), 16879-90. doi:10.1074/jbc.M110.186932

Ahrabi, A. K., JOURET, F., Marbaix, E., Delporte, C., Horie, S., Mulroy, S., Boulter, C., Sandford, R., & Devuyst, O. (2010). Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion. Nephrology Dialysis Transplantation, 25 (4), 1067-78. doi:10.1093/ndt/gfp611

JOURET, F., Castanares-Zapatero, D., & Laterre, P.-F. (2010). Delayed colopericardial fistula and pyopneumopericardium. Intensive Care Medicine, 36 (3), 557-8. doi:10.1007/s00134-009-1701-3

JOURET, F., Dupont, M., Jouret-Mourin, A., & Castanares Zapatero, D. (2010). Pneumatosis intestinalis and arcuate ligament. Acta Clinica Belgica, 65 (2), 138-9. doi:10.1179/acb.2010.029

JOURET, F., Walrand, S., Parreira, K. S., Courtoy, P. J., Pauwels, S., Devuyst, O., & Jamar, F. (2010). Single photon emission-computed tomography (SPECT) for functional investigation of the proximal tubule in conscious mice. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 298 (2), 454-60. doi:10.1152/ajprenal.00413.2009

Reed, A. A. C., Loh, N. Y., Terryn, S., Lippiat, J. D., Partridge, C., Galvanovskis, J., Williams, S. E., JOURET, F., Wu, F. T. F., Courtoy, P. J., Nesbit, M. A., Rorsman, P., Devuyst, O., Ashcroft, F. M., & Thakker, R. V. (2010). CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 298 (2), 365-80. doi:10.1152/ajprenal.00038.2009

Senou, M., Khalifa, C., Thimmesch, M., JOURET, F., Devuyst, O., Col, V., Audinot, J.-N., Lipnik, P., Moreno, J. C., Van Sande, J., Dumont, J. E., Many, M.-C., Colin, I. M., & Gerard, A.-C. (2010). A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid. Journal of Clinical Endocrinology and Metabolism, 95 (8), 4021-30. doi:10.1210/jc.2010-0228

JOURET, F., & Col, V. (2009). Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma. Acta Clinica Belgica, 64 (5), 457. doi:10.1179/acb.2009.078

JOURET, F., & Devuyst, O. (2009). CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflügers Archiv: European Journal of Physiology, 457 (6), 1227-36. doi:10.1007/s00424-008-0594-2

Morelle, J., Labriola, L., Lambert, M., Cosyns, J.-P., JOURET, F., & Jadoul, M. (2009). Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction. Clinical Nephrology, 71 (5), 567-70. doi:10.5414/CNP71567

Segner, S., JOURET, F., Durant, J.-F., Marot, L., & Kanaan, N. (2009). Cutaneous infection by Alternaria infectoria in a renal transplant patient. Transplant Infectious Disease, 11 (4), 330-2. doi:10.1111/j.1399-3062.2009.00420.x

Jouret, F., Differding, S., Lhommel, R., Jadoul, M., & Lambert, M. (2008). A mysterious 'homesickness'. NDT Plus, 1 (5), 371-2. doi:10.1093/ndtplus/sfn093

JOURET, F., Gailly, P., Martin, D., Debaix, H., Parreira, K. S., Nishita, T., Blanchard, A., Antignac, C., Willnow, T. E., Courtoy, P. J., Scheinman, S. J., Christensen, E. I., & Devuyst, O. (2008). A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction. Kidney International, 74 (1), 52-61. doi:10.1038/sj.ki.5002794

JOURET, F., Noirhomme, S., Grandin, C., Lonneux, M., Godfraind, C., Lambert, M., & Lefebvre, C. (2008). Atteinte cerebrale au cours d'une maladie de Wegener. Revue de Médecine Interne, 29 (11), 912-6. doi:10.1016/j.revmed.2008.04.003

JOURET, F., & Pirson, Y. (2008). Ingenierie tissulaire du parenchyme renal : une hypothese therapeutique ? MS. Medecine Sciences, 24 (6-7), 561-3. doi:10.1051/medsci/20082467561

Lambert, M., JOURET, F., Lonneux, M., & Jamar, F. (2008). Mismatch of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnetate thyroid scan in subacute thyroiditis. Acta Clinica Belgica, 63 (3), 209-10. doi:10.1179/acb.2008.034

JOURET, F., Bernard, A., Hermans, C., Dom, G., Terryn, S., Leal, T., Lebecque, P., Cassiman, J.-J., Scholte, B. J., de Jonge, H. R., Courtoy, P. J., & Devuyst, O. (2007). Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney. Journal of the American Society of Nephrology, 18 (3), 707-18. doi:10.1681/ASN.2006030269

Terryn, S., JOURET, F., Vandenabeele, F., Smolders, I., Moreels, M., Devuyst, O., Steels, P., & Van Kerkhove, E. (2007). A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 293 (2), 476-85. doi:10.1152/ajprenal.00363.2006

JOURET, F. (2006). Chloride transporters and vacuolar H+-ATPase in nephrogenesis and congenital tubulopathies [Doctoral thesis, UCL - Université Catholique de Louvain]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/134994

Sacre, A., JOURET, F., Manicourt, D., & Devuyst, O. (2006). Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrology Dialysis Transplantation, 21 (10), 2995-6. doi:10.1093/ndt/gfl251

van den Hove, M.-F., Croizet-Berger, K., JOURET, F., Guggino, S. E., Guggino, W. B., Devuyst, O., & Courtoy, P. J. (2006). The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. Endocrinology, 147 (3), 1287-96. doi:10.1210/en.2005-1149

Devuyst, O., JOURET, F., Auzanneau, C., & Courtoy, P. J. (2005). Chloride channels and endocytosis: new insights from Dent's disease and ClC-5 knockout mice. Nephron. Clinical Practice, 99 (3), 69-73. doi:10.1159/000083210

JOURET, F., Auzanneau, C., Debaix, H., Wada, G.-H. S., Pretto, C., Marbaix, E., Karet, F. E., Courtoy, P. J., & Devuyst, O. (2005). Ubiquitous and kidney-specific subunits of vacuolar H+-ATPase are differentially expressed during nephrogenesis. Journal of the American Society of Nephrology, 16 (11), 3235-46. doi:10.1681/ASN.2004110935

Smith, A. N., JOURET, F., Bord, S., Borthwick, K. J., Al-Lamki, R. S., Wagner, C. A., Ireland, D. C., Cormier-Daire, V., Frattini, A., Villa, A., Kornak, U., Devuyst, O., & Karet, F. E. (2005). Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone. Journal of the American Society of Nephrology, 16 (5), 1245-56. doi:10.1681/ASN.2004090761

JOURET, F., Debaix, H., & Devuyst, O. (2004). A catalog of gene expression in the developing kidney. Kidney International, 66 (2), 867-8. doi:10.1111/j.1523-1755.2004.814_4.x

JOURET, F., Igarashi, T., Gofflot, F., Wilson, P. D., Karet, F. E., Thakker, R. V., & Devuyst, O. (2004). Comparative ontogeny, processing, and segmental distribution of the renal chloride channel, ClC-5. Kidney International, 65 (1), 198-208. doi:10.1111/j.1523-1755.2004.00360.x